Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy

Annals of Nuclear Medicine

Volumn 20, Issue 4, 2006, Pages 287-294

  Semba, Takatoshi ^a   Sugawara, Yoshifumi ^a   Ochi, Takashi ^a   Fujii, Takashi ^a   Mochizuki, Teruhito ^a   Ohnishi, Takanori ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Glioma; Prognosis; Radiotherapy; SPECT; Thallium 201

Indexed keywords

CARBOPLATIN; ETOPOSIDE; NIMUSTINE; THALLIUM 201;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MALE; NEUROIMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CRANIOTOMY; FEMALE; GLIOMA; HUMANS; JAPAN; MALE; MIDDLE AGED; POSTOPERATIVE CARE; PROGNOSIS; RADIOPHARMACEUTICALS; RADIOTHERAPY; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; THALLIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 33745842549     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02984645     Document Type: Article

References (25)

1. Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol 2003; 30 (6 suppl 19): 4-9.
2. Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J. Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach. J Cancer Res Clin Oncol 2003; 129: 477-484.
3. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol 2003; 30 (6 suppl 19): 10-14.
4. Vos MJ, Hoekstra OS, Barkhof F, Berkhof J, Heimans JJ, van Groeningen CJ, et al. Thallium-201 single-photon emission computed tomography as an early predictor of outcome in recurrent glioma. J Clin Oncol 2003; 21: 3559-3565.
5. Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. Am J Neuroradiol 2004; 25: 214-221.
6. Tarnawski R, Sokol M, Pieniazek P, Maciejewski B, Walecki J, Miszczyk L, et al. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys 2002; 52: 1271-1276.
7. Ricci PE. Imaging of adult brain tumors. Neuroimaging Clin N Am 1999; 9: 651-669.
8. 201Tl SPECT imaging to assess the response to therapy in patients with high grade gliomas. J Neurooncol 2002; 59: 81-90.
9. 201Tl scintigraphy in evaluating proliferative activity in thyroid neoplasms. Ann Nucl Med 1996; 10: 41-48.
10. 201Tl accumulation on single photon emission computed tomography in benign and malignant thoracic lesions. Nucl Med Commun 1993; 14: 1071-1078.
11. Kaplan WD, Takvorian T, Morris JH, Rumbaugh CL, Connolly BT, Atkins HL. Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. J Nucl Med 1987; 28: 47-52.
12. Vertosick FT Jr, Selker RG, Grossman SJ, Joyce JM. Correlation of thallium-201 single photon emission computed tomography and survival after treatment failure in patients with glioblastoma multiforme. Neurosurgery 1994; 34: 396-401.
13. Lorberboym M, Mandell LR, Mosesson RE, Germano I, Lou W, DaCosta M, et al. The role of thallium-201 uptake and retention in intracranial tumor after radiotherapy. J Nucl Med 1997; 38: 223-226.
14. 201Tl SPECT). Nucl Med Commun 1993; 14: 1050-1060.
15. Black KL, Emerick T, Hoh C, Hawkins RA, Mazziotta J, Becker DP. Thallium-201 SPECT and positron emission tomography equal predictors of glioma grade and recurrence. Neurol Res 1994; 16: 93-96.
16. Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003; 33: 148-162.
17. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N, Tateno M, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histologic grade, prognosis and proliferative activities. J Nucl Med 1993; 34: 2085-2089.
18. Higa T, Maetani S, Kobashi Y, Nabeshima S. Tl-201 SPECT compared with histopathologic grade in the prognostic assessment of cerebral gliomas. Clin Nucl Med 2001; 26: 119-124.
19. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, et al. Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 1994; 30: 1201-1206.
20. Black KL, Hawkins RA, Kim KT, Becker DP, Lerner C, Marciano D. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg 1989; 71: 342-346.
21. Jinnouchi S, Hoshi H, Ohnishi T, Futami S, Nagamachi S, Watanabe K, et al. Thallium-201 SPECT for predicting histological type of meningiomas. J Nucl Med 1993; 34: 2091-2094.
22. 201Tl SPECT imaging of brain tumor. J Nucl Med 2000; 41: 5-10.
23. Baumert BG, Lutterbach J, Bernays R, Davis JB, Heppner FL. Fractionated stereotactic radiotherapy boost after postoperative radiotherapy in patients with high-grade gliomas. Radiother Oncol 2003; 67: 183-190.
24. Thilmann C, Zabel A, Grosser KH, Hoess A, Wannenmacher M, Debus J. Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer 2001; 96: 341-349.
25. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2005; 32: 52-59.